Apyx Medical Corp
APYX
Get informed when a big investor buys or sells
+ FollowMarket Cap$129.7M
Close$
$-4.04
232% downside
Current Fair Value
232% downsideOvervalued by 232% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $129.70 Million |
|---|---|
| Enterprise Value | $141.71 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.27 |
| Beta | 1.35 |
| Outstanding Shares | 42,163,000 |
Return
| Return on Equity | -80.97% |
|---|---|
| Return on Assets | -14.14% |
| Return on Invested Capital | -8.19% |
Valuation & Multiples
| P/E Ratio | -14.9 |
|---|---|
| PEG | 105.22 |
| Price to Sales | 3.06 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.43 |
| Enterprise Value to EBIT | -33.45 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | 3.72 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$13.18 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$13.30 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 83,100▼ 4.26% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 50.54%▲ 1.19% |
|---|---|
| Total Invested | $95.68M▲ 24.60% |
| Investors Holding | 70▲ 2.00% |
ESG Score
No data
About Apyx Medical Corp
CEO: Charles Goodwin